HModEx® is an open source health economic model marketplace, currently dedicated to oncology models. We offer validated models (using the CDA-AMA and other validation tools), as well as use of an extensive (NCIt) oncology ontology to classify and search for models and paid options, such as use of additional data sources for operational/external validity.
International Expert Advisory Panel
Click pictures for short bios
J. Robert Beck,
MD
Cofounder,
Society for Medical Decision Making, Former Deputy Director,
Fox Chase Cancer Center.
Philadelphia, USA
Andrew Briggs,
PhD
Professor of Health Economics and co-director of the Global Health ECOnomics (GHECO) Centre at the London School of Hygiene & Tropical Medicine.
London, UK
Joseph DiCesare, MPH
Former Lead, Real World Evidence and Economic Modeling, Allergan Pharmaceuticals; former VP, Global Health Economics and Outcomes Research, Novartis Pharma AG, Head, Health Economics & Outcomes, Basking Ridge, USA
Talitha Feenstra,
PhD
Associate Professor, Groningen University; National Institute for Public Health and the Environment (RIVM), Science and Engineering.
Netherlands
Natalia Kunst,
PhD
Senior Research Fellow (Associate Professor) at the Centre for Health Economics, University of York & Research Affiliate at Yale Schools of Public Health and Medicine, London, UK
Aryana Sepassi, PharmD, MAS
Assistant Professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.
San Diego, USA
Mark Roberts, MD, MPP
Distinguished Professor and Director, Public Health Dynamics Lab, University of Pittsburgh School of Public Health, Pittsburgh, USA
Michael Drummond, PhD
Professor,
Centre for Health Economics,
University of York,
York, UK
Ron Handels,
PhD
Assistant Professor at
the Alzheimer Centre Limburg at Maastricht University,
Netherlands
Raymond Henderson, PhD
Senior HTA Manager at
Salutem Insights Ltd.
Ireland, UK
Xavier Pouwels,
PhD
Researcher in Health Technology Assessment at University of Twente, Netherlands
Chris Sampson,
PhD
Senior Principal Economist at Office of Health Economics,
London, UK